Industry-Academia Collaboration:
Core Biomedical Inc. has stationed at Chang Gung Innovation Incubation Center, collaborating interdisciplinary with Chang Gung University's Health Aging Center Metabolomics Core Laboratory and Silicon Molecular Electronic Technology Inc. Core Biomedical, with its exclusive nucleic acid screening modification technology, integrates clinical research experience and metabolomics resources from Chang Gung University. Utilizing data from mass spectrometry analysis, they identify disease-related small molecule markers. Coupled with semiconductor biomedical chip detection platform from Silicon Molecular Electronic Technology, they develop highly sensitive and real-time efficient disease metabolite small molecule detection products.
Core Technology:
Through nucleic acid sequence design, special structure screening, computer simulation prediction, and mature optimization techniques, they develop secondary or tertiary structures with special functions. These structures possess high specificity, affinity, and stability, accurately identifying targets like ions, small molecules, proteins, cells, tissues, and microorganisms.